Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 5
2004 5
2005 4
2006 7
2007 3
2008 3
2009 4
2010 4
2011 6
2012 4
2013 6
2014 11
2015 6
2016 5
2017 11
2018 11
2019 15
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

112 results
Results by year
Filters applied: . Clear all
Page 1
Amphiregulin.
Berasain C, Avila MA. Berasain C, et al. Among authors: avila ma. Semin Cell Dev Biol. 2014 Apr;28:31-41. doi: 10.1016/j.semcdb.2014.01.005. Epub 2014 Jan 23. Semin Cell Dev Biol. 2014. PMID: 24463227 Review.
Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis.
Argemi J, Latasa MU, Atkinson SR, Blokhin IO, Massey V, Gue JP, Cabezas J, Lozano JJ, Van Booven D, Bell A, Cao S, Vernetti LA, Arab JP, Ventura-Cots M, Edmunds LR, Fondevilla C, Stärkel P, Dubuquoy L, Louvet A, Odena G, Gomez JL, Aragon T, Altamirano J, Caballeria J, Jurczak MJ, Taylor DL, Berasain C, Wahlestedt C, Monga SP, Morgan MY, Sancho-Bru P, Mathurin P, Furuya S, Lackner C, Rusyn I, Shah VH, Thursz MR, Mann J, Avila MA, Bataller R. Argemi J, et al. Among authors: avila ma. Nat Commun. 2019 Jul 16;10(1):3126. doi: 10.1038/s41467-019-11004-3. Nat Commun. 2019. PMID: 31311938 Free PMC article.
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting.
Avila MA, Dufour JF, Gerbes AL, Zoulim F, Bataller R, Burra P, Cortez-Pinto H, Gao B, Gilmore I, Mathurin P, Moreno C, Poznyak V, Schnabl B, Szabo G, Thiele M, Thursz MR. Avila MA, et al. Gut. 2020 Apr;69(4):764-780. doi: 10.1136/gutjnl-2019-319720. Epub 2019 Dec 26. Gut. 2020. PMID: 31879281 Review.
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies.
San José-Enériz E, Agirre X, Rabal O, Vilas-Zornoza A, Sanchez-Arias JA, Miranda E, Ugarte A, Roa S, Paiva B, Estella-Hermoso de Mendoza A, Alvarez RM, Casares N, Segura V, Martín-Subero JI, Ogi FX, Soule P, Santiveri CM, Campos-Olivas R, Castellano G, de Barrena MGF, Rodriguez-Madoz JR, García-Barchino MJ, Lasarte JJ, Avila MA, Martinez-Climent JA, Oyarzabal J, Prosper F. San José-Enériz E, et al. Among authors: avila ma. Nat Commun. 2017 May 26;8:15424. doi: 10.1038/ncomms15424. Nat Commun. 2017. PMID: 28548080 Free PMC article.
Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk.
Al-Aqil FA, Monte MJ, Peleteiro-Vigil A, Briz O, Rosales R, González R, Aranda CJ, Ocón B, Uriarte I, de Medina FS, Martinez-Augustín O, Avila MA, Marín JJG, Romero MR. Al-Aqil FA, et al. Among authors: avila ma. Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):2927-2937. doi: 10.1016/j.bbadis.2018.06.003. Epub 2018 Jun 6. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29883717 Free article.
Chromatin dynamics during liver regeneration.
Arechederra M, Berasain C, Avila MA, Fernández-Barrena MG. Arechederra M, et al. Among authors: avila ma. Semin Cell Dev Biol. 2020 Jan;97:38-46. doi: 10.1016/j.semcdb.2019.03.004. Epub 2019 Apr 9. Semin Cell Dev Biol. 2020. PMID: 30940574 Review.
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Banales JM, Iñarrairaegui M, Arbelaiz A, Milkiewicz P, Muntané J, Muñoz-Bellvis L, La Casta A, Gonzalez LM, Arretxe E, Alonso C, Martínez-Arranz I, Lapitz A, Santos-Laso A, Avila MA, Martínez-Chantar ML, Bujanda L, Marin JJG, Sangro B, Macias RIR. Banales JM, et al. Among authors: avila ma. Hepatology. 2019 Aug;70(2):547-562. doi: 10.1002/hep.30319. Epub 2019 Feb 14. Hepatology. 2019. PMID: 30325540 Free PMC article.
Emerging therapies for acute intermittent porphyria.
Fontanellas A, Ávila MA, Berraondo P. Fontanellas A, et al. Among authors: avila ma. Expert Rev Mol Med. 2016 Nov 2;18:e17. doi: 10.1017/erm.2016.18. Expert Rev Mol Med. 2016. PMID: 27804912 Review.
Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J, Zhang N, Sun H, Su L, Zhang C, Xu H, Feng J, Wang M, Chen J, Liu L, Shan J, Shen J, Yang Z, Wang G, Zhou H, Prieto J, Ávila MA, Liu C, Qian C. Xiang J, et al. Among authors: avila ma. Gastroenterology. 2020 Feb;158(3):664-678.e24. doi: 10.1053/j.gastro.2019.10.025. Epub 2019 Oct 31. Gastroenterology. 2020. PMID: 31678303
Messenger RNA therapy for rare genetic metabolic diseases.
Berraondo P, Martini PGV, Avila MA, Fontanellas A. Berraondo P, et al. Among authors: avila ma. Gut. 2019 Jul;68(7):1323-1330. doi: 10.1136/gutjnl-2019-318269. Epub 2019 Feb 22. Gut. 2019. PMID: 30796097 Review.
112 results
Jump to page
Feedback